Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#192 most reported symptom for this vaccine
Urine analysis normal has been reported 145 times in association with Tdap (Boostrix) vaccination in VAERS. This represents 0.3% of all 52,846 reports for this vaccine.
Among these reports, 1 mentioned death (0.69%) and 23 involved hospitalization (15.9%).
Urine analysis normal is the #192 most frequently reported symptom for Tdap (Boostrix) out of 2243 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 145 reports of Urine analysis normal after Tdap (Boostrix) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.69%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.